Skip to main content

Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions

Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener

ETF Screener
Comparison Tool
New Launches
ETF Providers

Technical Chart

Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap

Market Newsletter

Stock Analysis Pro

Inhibikase Therapeutics, Inc. (IKT)

NASDAQ: IKT · Real-Time Price · USD

1.830

+0.150 (8.93%)

Jun 18, 2026, 4:00 PM EDT - Market closed

Overview
Financials
Forecast
Statistics
History
Profile

Profile
Transcripts
Filings
Employees

Inhibikase Therapeutics Filings

Data Source: Quartr Last updated: May 12, 2026

Filings and investor relations documents are provided by Quartr and taken directly from SEC filings and official sources, including annual reports, quarterly reports, presentations, and press releases.

Update frequency:: Quarterly

Data Sources Report a data error

Install The App

Sections

Stocks
IPOs
ETFs
Blog

Services

Stock Analysis Pro
Free Newsletter
Get Support
Install The App

Website

Login
Create Account
Changelog
Sitemap
Advertise
FAQ

Company

About
Contact Us
Terms of Use
Privacy Policy
Data Sources
Affiliate Program

Market Newsletter

Daily market news in bullet point format.

Site Theme

© 2026 StockAnalysis.com. All rights reserved.